Canadian application, no grantCanada
Method for treatment of migraine using pde5 inhibitors
CA 2419623 A1 · Owner: Lilly Icos Llc · Inventors: Porst, Hartmut
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating migraine using a PDE5 inhibitor alone or in combination , with a second PDE5 inhibitor and/or other antimigraine agents is disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 27, 2001
GrantedNo grant recorded
Term endedAugust 27, 2021
Patent numberCA 2419623 A1
Classification (IPC)A61K31/49 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.